Please login to the form below

Not currently logged in
Email:
Password:

Astellas' EMEA president Ken Jones resigns

He will be succeeded by the firm's marketing head Yukio Matsui

Astellas Ken Jones

He joined Yamanouchi as vice president, European marketing, in 2003 ahead of its 2005 merger with Fujisawa to form Astellas, and prior that spent 16 years at Allergan working in Europe, the US and Japan.

Jones' replacement at Astellas will be Yukio Matsui, who currently serves as senior vice president, head of marketing strategy for Astellas' global strategic products.

Yoshihiko Hatanaka, Astellas' president and CEO, said: “The appointment of Yukio Matsui as president of EMEA Operations brings more than 30 years experience to the role - including various important positions in all four regions including Japan, Americas, EMEA, and Asia/Oceania.

“This experience will be crucial in securing the future success of Astellas for all stakeholders and helping the organisation to stay focused on our vision to be on the forefront of healthcare change to turn innovative science into value for patients." 

During his time at Astellas Matsui has held a variety of sales, marketing and strategic planning roles and will start in his new role on 1 April.

He said: "I join at an exciting time with recent launches of a number of innovative medicines and a compelling pipeline in late-stage clinical development for our region.

“With my international business experiences in both developed countries as well as emerging countries and the combined talents of more than 4,700 colleagues across all the functions in the EMEA region, I am confident we will deliver on the Astellas promise of improving the lives of those patients who depend on our medicines."

7th March 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....
Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...

Infographics